Precision's Shafrin Writes of the Value of Real-World Evidence in Drug Discovery & Development


In a new article for Drug Discovery & Development, Precision Health Economics senior research economist Jason Shafrin addresses the use of real-world evidence, why we need it and how to effectively implement it.

To read the complete article, please click here.